Eikon Therapeutics is heading to…
Eikon Therapeutics is heading to the Nasdaq this morning with [...]
As Eli Lilly awaits an FDA…
As Eli Lilly awaits an FDA approval decision for its [...]
Novartis has nixed six early-stage…
Novartis has nixed six early-stage pipeline programs, swapping in two [...]
Stem cell therapy biotech PrimeGen…
Stem cell therapy biotech PrimeGen US is taking the less-traveled [...]
As the first CAR-T treatment for…
As the first CAR-T treatment for an autoimmune disease draws [...]
Pfizer has pumped the brakes on…
Pfizer has pumped the brakes on six early-stage assets, including [...]
Exxel Pharma is eyeing a listing…
Exxel Pharma is eyeing a listing on the NYSE American [...]
Wave Life Sciences has the fate of…
Wave Life Sciences has the fate of its lead RNA [...]
Daiichi Sankyo’s development of…
Daiichi Sankyo’s development of ADCs continues to hit turbulence. The [...]
Having already secured regional…
Having already secured regional rights to vTv Therapeutics’ inflammation drug, [...]